Clinical utility gene card for: Dyskeratosis congenita

European Journal of Human Genetics

Volumn 19, Issue 11, 2011, Pages

  Dokal, Inderjeet ^a   Vulliamy, Tom ^a   Mason, Philip ^b   Bessler, Monica ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSKERIN; TELOMERASE; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; NOLA2 PROTEIN, HUMAN; NOP10 PROTEIN, HUMAN; NUCLEAR PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TELOMERE BINDING PROTEIN; TERT PROTEIN, HUMAN; TINF2 PROTEIN, HUMAN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DYSKERATOSIS CONGENITA; MYELODYSPLASTIC SYNDROME; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; GENETICS; HUMAN; MUTATION;

CELL CYCLE PROTEINS; DYSKERATOSIS CONGENITA; HUMANS; MUTATION; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; TELOMERASE; TELOMERE-BINDING PROTEINS;

EID: 80054808620     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.90     Document Type: Article

References (9)

1. Alter BP, Baerlocher GM, Savage SA et al: Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007; 110: 1439-1447 (Pubitemid 47443958)
2. Bessler M, Wilson BD, Mason PJ: Dyskeratosis congenita. FEBS Lett 2010; 584: 3831-3838
3. Calado RT, Young NS: Telomere Diseases. N Engl J Med 2009; 361: 2353-2365
4. Du HY, Pumbo E, Ivanovich J et al: TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009; 113: 309-316
5. Fogarty PF, Yamaguchi H, Wiestner A et al: Late presentation of dyskeratosis congenita as apparently acquired aplstic anaemia due to mutations in telomerase RNA. Lancet 2003; 362: 1628-1630 (Pubitemid 37443532)
6. Savage SA, Dokal I, Armanios M et al: Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer 2009; 53: 520-523
7. Vulliamy TJ, Marrone M, Knight S, Walne A, Mason PJ, Dokal I: Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680-2685
8. Vulliamy TJ, Knight SW, Mason PJ, Dokal I: Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27: 353-377
9. Walne AJ, Dokal I: Advances in the understanding of Dyskeratosis Congenita. Br J Haematol 2009; 145: 164-172